Loiacono Michael 4
4 · Marker Therapeutics, Inc. · Filed Mar 1, 2023
Insider Transaction Report
Form 4
Loiacono Michael
Chief Financial Officer
Transactions
- Award
Employee Stock Option (right to buy)
2023-02-27+38,480→ 38,480 totalExercise: $2.14Exp: 2033-02-27→ Common Stock (38,480 underlying)
Footnotes (1)
- [F1]This option vests in equal monthly installments over a four year period commencing on March 27, 2023 subject to the continued service by the Reporting Person to the Issuer as of the applicable vesting date.